Inozyme Pharma (INZY)
NASDAQ:INZY
US Market

Inozyme Pharma (INZY) Stock Investors

244 Followers
Based on 685,900 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold INZY
On average, investors allocate 3.85% of their portfolios to INZY
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 685,900 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding INZY

3.8%
Last 7
Days
10.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding INZY, out of 685,900 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

INZY Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
2.68%
$4.28
Increased
0.08%
$5.68
Opened
0.00%
$5.74
Increased
0.31%
Based on the activity of 12,699 investors who made their portfolios public
The table shows changes in INZY in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

INZY Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.56%
-1.32%
+774.37%
498.25M
Healthcare
Moderna
5.12%
+0.53%
-1.91%
39.40B
Healthcare
ChargePoint Holdings
4.60%
-0.10%
+0.08%
1.87B
Technology
Syros Pharmaceuticals
4.07%
-1.71%
-7.28%
81.18M
Healthcare
Marvell
4.80%
+0.11%
+3.40%
45.68B
Technology
Assertio Therapeutics
3.12%
-1.20%
-5.89%
243.01M
Healthcare
Merck & Company
4.64%
-0.51%
-2.87%
272.30B
Healthcare
Roku
5.13%
-0.73%
-2.17%
8.87B
Technology
Micron
5.65%
+0.30%
-2.39%
76.32B
Technology
Block
4.25%
+0.16%
-0.27%
26.14B
Technology
Based on the activity of 685,900 active portfolios
Open your Smart Portfolio

INZY Investor Analysis

INZY investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
17.5%
of INZY holders
are under 35
Average Segment Performance
Average P/E Ratio-28.27
Beta9.48
Dividend Yield5.31%
INZY investors between 35–55

Between 35–55

26.6%
Last 30 days
Holdings Change
50.0%
of INZY holders
are between 35–55
Average Segment Performance
Average P/E Ratio-25.67
Beta14.52
Dividend Yield18.48%
INZY investors over 55

Over 55

12.4%
Last 30 days
Holdings Change
32.5%
of INZY holders
are over 55
Average Segment Performance
Average P/E Ratio-18.77
Beta5.45
Dividend Yield5.10%
Overview of age group and performance of INZY stock investors
See who invests in INZY according to age group and performance.

FAQ

How many retail Investors hold INZY?
<0.1% of TipRank’s retail investors hold INZY in their portfolios.
    What is INZY Investor Sentiment?
    INZY’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of INZY in the last 7 days?
      ▲ 3.8% of TipRank’s retail investors changed their holding of INZY in the last 7 days.
        What percentage of retail investors changed their holding of INZY in the last 30 days?
        ▲ 10.0% of TipRank’s retail investors changed their holding of INZY in the last 30 days.
          What is the average age of retail investors who hold INZY?
          The average age of INZY Holders is between 35–55.
            What other stocks have INZY investors also bought?
            INZY Investors also bought CHRS, MRNA, CHPT, SYRS, MRVL, ASRT, MRK, ROKU, MU, SQ.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AMRNAmarin
              BSXBoston Scientific
              CNCCentene
              CHRSCoherus Biosciences

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis